omeprazole has been researched along with Equine Diseases in 53 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Excerpt | Relevance | Reference |
---|---|---|
"Equine gastric ulcer syndrome (EGUS) is the most common disease of the stomach in horses and treatment is based on the oral administration of omeprazole for at least 28 days." | 9.69 | A Comparison of the Efficacy of Two Omeprazole Formulations in the Treatment of Equine Gastric Ulcer Syndrome in Racehorses: A Blinded, Randomized Clinical Trial. ( Busechian, S; Conte, G; Conti, MB; Marchesi, MC; Pieramati, C; Rueca, F; Sgorbini, M; Vitale, V; Zappulla, F, 2023) |
" Anecdotally, many practitioners prescribe omeprazole concurrently with phenylbutazone to reduce development of equine gastric ulcer syndrome (EGUS), but the efficacy and safety of this practice remains unknown." | 9.41 | Impact of concurrent treatment with omeprazole on phenylbutazone-induced equine gastric ulcer syndrome (EGUS). ( Andrews, FM; Banse, HE; Chapman, A; Garza, F; Keowen, M; Paul, L; Ricord, M; Yñiguez, FJM, 2021) |
"To test the hypothesis that aloe vera would be noninferior to omeprazole in the treatment of equine gastric ulcer syndrome." | 9.27 | Comparison of aloe vera and omeprazole in the treatment of equine gastric ulcer syndrome. ( Bush, J; Franklin, S; van den Boom, R, 2018) |
"To further investigate the presence of a dose relationship in the treatment of gastric ulceration under conditions that may favour omeprazole efficacy such as administration prior to exercise and after a brief fast, and potential differences between the response of squamous and glandular ulceration to omeprazole therapy." | 9.20 | A comparison of three doses of omeprazole in the treatment of equine gastric ulcer syndrome: A blinded, randomised, dose-response clinical trial. ( Hallowell, GD; Sykes, BW; Sykes, KM, 2015) |
"To compare: 1) the efficacy of 2 doses of omeprazole in the treatment of primary squamous and glandular gastric ulceration; and 2) the healing response of primary squamous and glandular gastric ulceration to acid suppression therapy." | 9.19 | A comparison of two doses of omeprazole in the treatment of equine gastric ulcer syndrome: a blinded, randomised, clinical trial. ( Hallowell, GD; Sykes, BW; Sykes, KM, 2014) |
"To determine the effects of 8 days of light to heavy exercise on gastric ulcer development in horses and determine the efficacy of omeprazole paste in preventing gastric ulceration." | 9.12 | Effects of short-term light to heavy exercise on gastric ulcer development in horses and efficacy of omeprazole paste in preventing gastric ulceration. ( Cramer, LG; Fleishman, C; Holste, JE; McClure, SR; Murray, MJ; Sifferman, R; White, G, 2007) |
"Omeprazole oral paste administered at a dosage of 1 mg/kg, PO, every 24 hours for 28 days was effective for prevention of recurrence of gastric ulcers in horses in race training." | 9.11 | Efficacy of omeprazole paste for prevention of recurrence of gastric ulcers in horses in race training. ( Alva, R; Bernard, W; Cramer, LG; Fleishman, C; Holste, JE; Hughes, FE; McClure, SR; Sifferman, RL; White, GW, 2005) |
"Results suggest that although administration of the commercially available paste omeprazole formulation was effective in promoting healing of gastric ulcers in these horses, administration of the compounded omeprazole suspension was ineffective." | 9.10 | Comparison of paste and suspension formulations of omeprazole in the healing of gastric ulcers in racehorses in active training. ( Aleman, MR; Nieto, JE; Pipers, FS; Smith, DC; Snyder, JR; Spier, S; Stanley, S, 2002) |
"A multicentre, blinded, randomised complete-block, field trial was conducted with 140 horses and foals age 4 weeks-28 years to determine if omeprazole paste is effective and safe in promoting healing of spontaneous gastric ulcers under a variety of field conditions and in different breeds and ages of horses." | 9.09 | Effects of omeprazole paste on healing of spontaneous gastric ulcers in horses and foals: a field trial. ( Cox, JL; Ericcson, GF; Holste, JE; MacAllister, CG; McClure, SR; Sifferman, RL; Vatistas, NJ; White, GW, 1999) |
"Seventeen Thoroughbred horses with moderate to severe gastric ulceration were purchased from a race track within 10 days of racing and were treated once daily with either omeprazole (9 horses) or vehicle (8 horses) and evaluated gastroscopically for ulcer healing." | 9.08 | Effects of omeprazole on healing of naturally-occurring gastric ulcers in thoroughbred racehorses. ( Eagleson, J; Eichorn, ES; Haven, ML; Hickey, GJ; Murray, MJ; Zhang, D, 1997) |
"In preventing gastric ulcer occurrence, omeprazole prophylaxis was superior to sham in training horses (7 trials, 566 horses, RR 0." | 9.01 | Prophylactic therapy with omeprazole for prevention of equine gastric ulcer syndrome (EGUS) in horses in active training: A meta-analysis. ( Mason, LV; Mason, RJ; Moroney, JR, 2019) |
"A 15-year-old Quarter Horse gelding and a 26-year-old Thoroughbred gelding were evaluated because of hematuria of 4 to 6 days' duration following prolonged oral administration of phenylbutazone." | 7.77 | Ulcerative cystitis associated with phenylbutazone administration in two horses. ( Aleman, M; Higgins, JK; Nieto, JE, 2011) |
"Following induction of gastric ulcers by intermittent feed deprivation, horses underwent sucrose permeability testing (administration of sucrose by nasogastric intubation followed by collection of urine at 2 and 4 hours after intubation) and gastric endoscopy." | 7.72 | Evaluation of urine sucrose concentration for detection of gastric ulcers in horses. ( Cohen, ND; Meddings, JB; O'Conner, MS; Pipers, F; Roussel, AJ; Steiner, JM; Williams, DA, 2004) |
"The efficacy of a paste formulation of the H+, K+, -ATPase inhibitor omeprazole was evaluated in standardbred racehorses for the treatment and prevention of gastric ulcers." | 7.72 | Efficacy of a paste formulation of omeprazole for the treatment of naturally occurring gastric ulcers in training standardbred racehorses in Canada. ( Alva, R; Dionne, R; Doucet, MY; Ericsson, G; Vrins, AA, 2003) |
"To compare pharmacokinetic and pharmacodynamic effects of a novel omeprazole formulation against a currently registered product." | 6.84 | Pharmacokinetic and pharmacodynamic effects of two omeprazole formulations on stomach pH and gastric ulcer scores. ( Andrews, FM; Nielsen, SG; Raidal, SL; Trope, G, 2017) |
"To determine the minimal effective dosage of omeprazole oral paste for the prevention of naturally occurring ulcers in horses starting race training." | 6.71 | Efficacy of omeprazole paste for prevention of gastric ulcers in horses in race training. ( Alva, R; Bernard, W; Cramer, LG; Doucet, MY; Fleishman, C; Holste, JE; McClure, SR; Sifferman, RL; Vrins, A; White, GW, 2005) |
" The results of this study suggest that omeprazole, employing a once daily dosing schedule, is effective at reducing the severity or eliminating gastric ulcers in Thoroughbreds in active race training." | 6.69 | Acceptability of a paste formulation and efficacy of high dose omeprazole in healing gastric ulcers in horses maintained in race training. ( Holste, J; Nieto, J; Pollmeier, M; Snyder, JR; Thompson, D; Vatistas, NJ, 1999) |
" At Day 28, 25 of treated horses continued on this dosing regimen while 25 received a half dose (2 mg/kg bwt once daily) and 25 horses were sham-dosed." | 6.69 | Efficacy of omeprazole paste in the treatment and prevention of gastric ulcers in horses. ( Alva, R; Andrews, FM; Bernard, W; Cox, JL; Daurio, CP; Holste, JE; Hughes, FE; Sifferman, RL, 1999) |
"Equine gastric ulcer syndrome (EGUS) is the most common disease of the stomach in horses and treatment is based on the oral administration of omeprazole for at least 28 days." | 5.69 | A Comparison of the Efficacy of Two Omeprazole Formulations in the Treatment of Equine Gastric Ulcer Syndrome in Racehorses: A Blinded, Randomized Clinical Trial. ( Busechian, S; Conte, G; Conti, MB; Marchesi, MC; Pieramati, C; Rueca, F; Sgorbini, M; Vitale, V; Zappulla, F, 2023) |
"This study was performed 1) to investigate the prevalence and the severity of gastric ulcers in Thoroughbred racehorses in Korea, 2) to confirm the therapeutic effect of ranitidine and omeprazole, and 3) to compare the efficacy between ranitidine and omeprazole." | 5.51 | Prevalence and treatment of gastric ulcers in Thoroughbred racehorses of Korea. ( Cho, S; Dong, HJ; Han, J; Hwang, H; Kim, Y; Lee, I, 2022) |
" Anecdotally, many practitioners prescribe omeprazole concurrently with phenylbutazone to reduce development of equine gastric ulcer syndrome (EGUS), but the efficacy and safety of this practice remains unknown." | 5.41 | Impact of concurrent treatment with omeprazole on phenylbutazone-induced equine gastric ulcer syndrome (EGUS). ( Andrews, FM; Banse, HE; Chapman, A; Garza, F; Keowen, M; Paul, L; Ricord, M; Yñiguez, FJM, 2021) |
"To test the hypothesis that aloe vera would be noninferior to omeprazole in the treatment of equine gastric ulcer syndrome." | 5.27 | Comparison of aloe vera and omeprazole in the treatment of equine gastric ulcer syndrome. ( Bush, J; Franklin, S; van den Boom, R, 2018) |
"To further investigate the presence of a dose relationship in the treatment of gastric ulceration under conditions that may favour omeprazole efficacy such as administration prior to exercise and after a brief fast, and potential differences between the response of squamous and glandular ulceration to omeprazole therapy." | 5.20 | A comparison of three doses of omeprazole in the treatment of equine gastric ulcer syndrome: A blinded, randomised, dose-response clinical trial. ( Hallowell, GD; Sykes, BW; Sykes, KM, 2015) |
"To compare: 1) the efficacy of 2 doses of omeprazole in the treatment of primary squamous and glandular gastric ulceration; and 2) the healing response of primary squamous and glandular gastric ulceration to acid suppression therapy." | 5.19 | A comparison of two doses of omeprazole in the treatment of equine gastric ulcer syndrome: a blinded, randomised, clinical trial. ( Hallowell, GD; Sykes, BW; Sykes, KM, 2014) |
"To determine the effects of 8 days of light to heavy exercise on gastric ulcer development in horses and determine the efficacy of omeprazole paste in preventing gastric ulceration." | 5.12 | Effects of short-term light to heavy exercise on gastric ulcer development in horses and efficacy of omeprazole paste in preventing gastric ulceration. ( Cramer, LG; Fleishman, C; Holste, JE; McClure, SR; Murray, MJ; Sifferman, R; White, G, 2007) |
"Omeprazole oral paste administered at a dosage of 1 mg/kg, PO, every 24 hours for 28 days was effective for prevention of recurrence of gastric ulcers in horses in race training." | 5.11 | Efficacy of omeprazole paste for prevention of recurrence of gastric ulcers in horses in race training. ( Alva, R; Bernard, W; Cramer, LG; Fleishman, C; Holste, JE; Hughes, FE; McClure, SR; Sifferman, RL; White, GW, 2005) |
"Results suggest that although administration of the commercially available paste omeprazole formulation was effective in promoting healing of gastric ulcers in these horses, administration of the compounded omeprazole suspension was ineffective." | 5.10 | Comparison of paste and suspension formulations of omeprazole in the healing of gastric ulcers in racehorses in active training. ( Aleman, MR; Nieto, JE; Pipers, FS; Smith, DC; Snyder, JR; Spier, S; Stanley, S, 2002) |
"Omeprazole has been shown to promote healing of spontaneously occurring gastric ulcers in horses when administered for 28 days at a dose of 4 mg/kg bwt/day and to prevent recurrence of ulcers in almost all horses when treatment is continued at a dose of at least 2 mg/kg bwt/day." | 5.09 | Safety of omeprazole paste in foals and mature horses. ( Attebery, DK; Cox, JL; Daurio, C; Plue, RE; Wall, HG; Wallace, DH, 1999) |
"A multicentre, blinded, randomised complete-block, field trial was conducted with 140 horses and foals age 4 weeks-28 years to determine if omeprazole paste is effective and safe in promoting healing of spontaneous gastric ulcers under a variety of field conditions and in different breeds and ages of horses." | 5.09 | Effects of omeprazole paste on healing of spontaneous gastric ulcers in horses and foals: a field trial. ( Cox, JL; Ericcson, GF; Holste, JE; MacAllister, CG; McClure, SR; Sifferman, RL; Vatistas, NJ; White, GW, 1999) |
"Seventeen Thoroughbred horses with moderate to severe gastric ulceration were purchased from a race track within 10 days of racing and were treated once daily with either omeprazole (9 horses) or vehicle (8 horses) and evaluated gastroscopically for ulcer healing." | 5.08 | Effects of omeprazole on healing of naturally-occurring gastric ulcers in thoroughbred racehorses. ( Eagleson, J; Eichorn, ES; Haven, ML; Hickey, GJ; Murray, MJ; Zhang, D, 1997) |
"In preventing gastric ulcer occurrence, omeprazole prophylaxis was superior to sham in training horses (7 trials, 566 horses, RR 0." | 5.01 | Prophylactic therapy with omeprazole for prevention of equine gastric ulcer syndrome (EGUS) in horses in active training: A meta-analysis. ( Mason, LV; Mason, RJ; Moroney, JR, 2019) |
"A 15-year-old Quarter Horse gelding and a 26-year-old Thoroughbred gelding were evaluated because of hematuria of 4 to 6 days' duration following prolonged oral administration of phenylbutazone." | 3.77 | Ulcerative cystitis associated with phenylbutazone administration in two horses. ( Aleman, M; Higgins, JK; Nieto, JE, 2011) |
" Beginning on day 14, horses were administered omeprazole (4 mg/kg, PO, q 24 h until day 56) or no drug (10 horses/group) and underwent alternating 24-hour periods of feeding and feed withholding for 10 days to induce gastric ulceration." | 3.75 | Effect of gastric ulceration on physiologic responses to exercise in horses. ( Jones, JH; Nieto, JE; Snyder, JR; Vatistas, NJ, 2009) |
"Results suggest that the proprietary formulation of omeprazole was associated with a significantly lower risk of moderate or severe gastric ulceration, compared with no treatment, in racehorses in active race training, whereas other antiulcer medications were not." | 3.72 | Odds of moderate or severe gastric ulceration in racehorses receiving antiulcer medications. ( Haddock, M; Orsini, JA; Rabuffo, TS; Smith, G; Stine, L; Sullivan, EK, 2003) |
"Following induction of gastric ulcers by intermittent feed deprivation, horses underwent sucrose permeability testing (administration of sucrose by nasogastric intubation followed by collection of urine at 2 and 4 hours after intubation) and gastric endoscopy." | 3.72 | Evaluation of urine sucrose concentration for detection of gastric ulcers in horses. ( Cohen, ND; Meddings, JB; O'Conner, MS; Pipers, F; Roussel, AJ; Steiner, JM; Williams, DA, 2004) |
"The efficacy of a paste formulation of the H+, K+, -ATPase inhibitor omeprazole was evaluated in standardbred racehorses for the treatment and prevention of gastric ulcers." | 3.72 | Efficacy of a paste formulation of omeprazole for the treatment of naturally occurring gastric ulcers in training standardbred racehorses in Canada. ( Alva, R; Dionne, R; Doucet, MY; Ericsson, G; Vrins, AA, 2003) |
"Gastric ulcers were induced through intermittent feed withholding on days 21 to 28." | 3.30 | Changes in Heart Rate Variability with Induction of Gastric Ulcers in Adult Horses. ( Berryhill, EH; Finno, CJ; Knych, H; Louie, EW; Morgan, JM; Nieto, J; Wensley, F, 2023) |
"A prospective, blinded randomized interventional study was trial, conducted in 3 parts: (a) bioavailability study, (b) dose titration study, and (c) comparative clinical pharmacodynamic study, each using a blocked crossover design." | 3.01 | Pharmacokinetic and pharmacodynamic effects of 2 registered omeprazole preparations and varying dose rates in horses. ( Edwards, S; Hughes, KJ; Jacobson, GA; Narkowicz, CK; Raidal, SL; Wise, JC, 2021) |
"Misoprostol was shown to be superior to combined omeprazole-sucralfate both for healing (M - 72% [95% CI 43-67] and OS - 20% [95% CI 7-41]; P<0." | 2.90 | Misoprostol is superior to combined omeprazole-sucralfate for the treatment of equine gastric glandular disease. ( Bowen, IM; Habershon-Butcher, JL; Hallowell, GD; Nicholls, V; Varley, G, 2019) |
"To compare pharmacokinetic and pharmacodynamic effects of a novel omeprazole formulation against a currently registered product." | 2.84 | Pharmacokinetic and pharmacodynamic effects of two omeprazole formulations on stomach pH and gastric ulcer scores. ( Andrews, FM; Nielsen, SG; Raidal, SL; Trope, G, 2017) |
"To determine the minimal effective dosage of omeprazole oral paste for the prevention of naturally occurring ulcers in horses starting race training." | 2.71 | Efficacy of omeprazole paste for prevention of gastric ulcers in horses in race training. ( Alva, R; Bernard, W; Cramer, LG; Doucet, MY; Fleishman, C; Holste, JE; McClure, SR; Sifferman, RL; Vrins, A; White, GW, 2005) |
"Omeprazole was more effective than ranitidine in healing gastric squamous ulcers in Thoroughbreds in race training." | 2.71 | Effects of treatment with omeprazole or ranitidine on gastric squamous ulceration in racing Thoroughbreds. ( Lester, GD; Robertson, ID; Smith, RL, 2005) |
" At Day 28, 25 of treated horses continued on this dosing regimen while 25 received a half dose (2 mg/kg bwt once daily) and 25 horses were sham-dosed." | 2.69 | Efficacy of omeprazole paste in the treatment and prevention of gastric ulcers in horses. ( Alva, R; Andrews, FM; Bernard, W; Cox, JL; Daurio, CP; Holste, JE; Hughes, FE; Sifferman, RL, 1999) |
" The results of this study suggest that omeprazole, employing a once daily dosing schedule, is effective at reducing the severity or eliminating gastric ulcers in Thoroughbreds in active race training." | 2.69 | Acceptability of a paste formulation and efficacy of high dose omeprazole in healing gastric ulcers in horses maintained in race training. ( Holste, J; Nieto, J; Pollmeier, M; Snyder, JR; Thompson, D; Vatistas, NJ, 1999) |
" The oral administration of omeprazole has been shown to be effective in both treating horses with gastric ulceration and at preventing re-occurrence whilst the horses are in training, provided that daily dosing is maintained." | 2.44 | Equine gastric ulcer syndrome in adult horses: a review. ( Bell, RJ; Kingston, JK; Mogg, TD, 2007) |
" Therefore, the use of singular dosing recommendations that encompass all horse types and management conditions may not be appropriate and dosing recommendations that take into account the diet of the horse may be advantageous." | 1.46 | The effects of dose and diet on the pharmacodynamics of omeprazole in the horse. ( Greer, R; McGowan, CM; Mills, PC; Sykes, BW; Underwood, C, 2017) |
"Optimal timing for daily dosing of athletic horses with an effective OME preparation, in order to suppress gastric squamous ulceration, might be 4-8 h prior to a training session." | 1.32 | Effect of GastroGard and three compounded oral omeprazole preparations on 24 h intragastric pH in gastrically cannulated mature horses. ( Burrow, JA; Church, M; Ludzia, S; Merritt, AM; Sanchez, LC, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (15.09) | 18.2507 |
2000's | 16 (30.19) | 29.6817 |
2010's | 18 (33.96) | 24.3611 |
2020's | 11 (20.75) | 2.80 |
Authors | Studies |
---|---|
Meinke, PT | 1 |
Gough, S | 2 |
Hallowell, G | 2 |
Rendle, D | 3 |
Hwang, H | 1 |
Dong, HJ | 1 |
Han, J | 1 |
Cho, S | 1 |
Kim, Y | 1 |
Lee, I | 1 |
Pratt, SL | 2 |
Bowen, M | 2 |
Hallowell, GH | 2 |
Shipman, E | 2 |
Bailey, J | 2 |
Redpath, A | 2 |
Louie, EW | 2 |
Berryhill, EH | 2 |
Nieto, J | 3 |
Wensley, F | 2 |
Knych, H | 2 |
Finno, CJ | 2 |
Morgan, JM | 2 |
Sundra, T | 1 |
Kelty, E | 1 |
Busechian, S | 1 |
Conti, MB | 1 |
Sgorbini, M | 1 |
Conte, G | 1 |
Marchesi, MC | 1 |
Pieramati, C | 1 |
Zappulla, F | 1 |
Vitale, V | 1 |
Rueca, F | 1 |
Luthersson, N | 1 |
Bolger, C | 1 |
Fores, P | 1 |
Barfoot, C | 1 |
Nelson, S | 1 |
Parkin, T | 1 |
Harris, P | 1 |
Pagan, JD | 1 |
Petroski-Rose, L | 1 |
Mann, A | 1 |
Hauss, A | 1 |
Ricord, M | 1 |
Andrews, FM | 5 |
Yñiguez, FJM | 1 |
Keowen, M | 1 |
Garza, F | 1 |
Paul, L | 1 |
Chapman, A | 1 |
Banse, HE | 1 |
Cerri, S | 1 |
Taminiau, B | 1 |
de Lusancay, AH | 1 |
Lecoq, L | 1 |
Amory, H | 1 |
Daube, G | 1 |
Cesarini, C | 1 |
Wise, JC | 1 |
Hughes, KJ | 1 |
Edwards, S | 1 |
Jacobson, GA | 1 |
Narkowicz, CK | 1 |
Raidal, SL | 2 |
Zavoshti, FR | 1 |
Sykes, BW | 6 |
Kathawala, K | 1 |
Song, Y | 1 |
Garg, S | 1 |
Page, SW | 1 |
Underwood, C | 2 |
Mills, PC | 2 |
Nielsen, SG | 1 |
Trope, G | 1 |
Bush, J | 1 |
van den Boom, R | 1 |
Franklin, S | 1 |
Huxford, KE | 1 |
Dart, AJ | 1 |
Perkins, NR | 1 |
Bell, R | 1 |
Jeffcott, LB | 1 |
Mason, LV | 1 |
Moroney, JR | 1 |
Mason, RJ | 1 |
Varley, G | 1 |
Bowen, IM | 1 |
Habershon-Butcher, JL | 1 |
Nicholls, V | 1 |
Hallowell, GD | 5 |
Sykes, KM | 3 |
Sykes, K | 1 |
Alwan, W | 1 |
Banerjee, P | 1 |
White, IR | 1 |
Al-Falah, K | 1 |
Schachter, J | 1 |
Sasseville, D | 1 |
Greer, R | 1 |
McGowan, CM | 1 |
Nieto, JE | 4 |
Snyder, JR | 4 |
Vatistas, NJ | 4 |
Jones, JH | 1 |
Aleman, M | 1 |
Higgins, JK | 1 |
Endo, Y | 1 |
Tsuchiya, T | 1 |
Sato, F | 1 |
Murase, H | 1 |
Omura, T | 1 |
Korosue, K | 1 |
Nambo, Y | 1 |
Ishimaru, M | 1 |
Wakui, Y | 1 |
Furr, M | 1 |
Cohen, ND | 2 |
Axon, JE | 1 |
Sanchez, LC | 3 |
Pantaleon, L | 1 |
Haggett, E | 1 |
Campbell, R | 1 |
Tennent-Brown, B | 1 |
Spier, S | 1 |
Pipers, FS | 1 |
Stanley, S | 1 |
Aleman, MR | 1 |
Smith, DC | 1 |
Doucet, MY | 2 |
Vrins, AA | 1 |
Dionne, R | 1 |
Alva, R | 4 |
Ericsson, G | 1 |
Orsini, JA | 1 |
Haddock, M | 1 |
Stine, L | 1 |
Sullivan, EK | 1 |
Rabuffo, TS | 1 |
Smith, G | 1 |
Merritt, AM | 1 |
Burrow, JA | 1 |
Church, M | 1 |
Ludzia, S | 1 |
O'Conner, MS | 1 |
Steiner, JM | 1 |
Roussel, AJ | 1 |
Williams, DA | 1 |
Meddings, JB | 1 |
Pipers, F | 1 |
McClure, SR | 4 |
White, GW | 3 |
Sifferman, RL | 4 |
Bernard, W | 3 |
Vrins, A | 1 |
Holste, JE | 5 |
Fleishman, C | 3 |
Cramer, LG | 3 |
Hughes, FE | 2 |
Lester, GD | 1 |
Smith, RL | 1 |
Robertson, ID | 1 |
Stämpfli, H | 1 |
Oliver, OE | 1 |
Graves, EA | 1 |
Bell, RJ | 1 |
Mogg, TD | 1 |
Kingston, JK | 1 |
White, G | 1 |
Sifferman, R | 1 |
Murray, MJ | 3 |
Javsicas, LH | 1 |
Haven, ML | 1 |
Eichorn, ES | 1 |
Zhang, D | 1 |
Eagleson, J | 1 |
Hickey, GJ | 1 |
Doherty, TJ | 1 |
Blackford, JT | 1 |
Nadeau, JA | 1 |
Saxton, AM | 1 |
Plue, RE | 1 |
Wall, HG | 1 |
Daurio, C | 1 |
Attebery, DK | 1 |
Cox, JL | 3 |
Wallace, DH | 1 |
Thompson, D | 2 |
Pollmeier, M | 1 |
Holste, J | 1 |
MacAllister, CG | 1 |
Ericcson, GF | 1 |
Daurio, CP | 1 |
van den Wollenberg, L | 1 |
Sloet van Oldruitenborgh-Oosterbaan, MM | 1 |
6 reviews available for omeprazole and Equine Diseases
Article | Year |
---|---|
Perspectives in animal health: old targets and new opportunities.
Topics: Animals; Anthelmintics; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Anti-Ulcer Age | 2001 |
Therapeutics for Equine Gastric Ulcer Syndrome.
Topics: Animals; Anti-Ulcer Agents; Horse Diseases; Horses; Omeprazole; Proton Pump Inhibitors; Stomach Ulce | 2017 |
Prophylactic therapy with omeprazole for prevention of equine gastric ulcer syndrome (EGUS) in horses in active training: A meta-analysis.
Topics: Animals; Anti-Ulcer Agents; Bias; Confidence Intervals; Female; Horse Diseases; Horses; Male; Odds R | 2019 |
Equine gastric ulcer syndrome in adult horses: a review.
Topics: Animal Husbandry; Animals; Anti-Ulcer Agents; Gastric Mucosa; Horse Diseases; Horses; Omeprazole; Ph | 2007 |
Suppression of gastric acidity in horses.
Topics: Animals; Anti-Ulcer Agents; Gastric Acid; Gastric Mucosa; Histamine H2 Antagonists; Horse Diseases; | 1997 |
[Gastric ulceration in horses: etiology, diagnosis, and therapy: a review].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Antacids; Anti-Ulcer Agents; Dose-Response Relatio | 2000 |
25 trials available for omeprazole and Equine Diseases
Article | Year |
---|---|
Prevalence and treatment of gastric ulcers in Thoroughbred racehorses of Korea.
Topics: Animals; Anti-Ulcer Agents; Horse Diseases; Horses; Omeprazole; Prevalence; Stomach Ulcer | 2022 |
Changes in Heart Rate Variability with Induction of Gastric Ulcers in Adult Horses.
Topics: Animals; Anti-Ulcer Agents; Heart Rate; Horse Diseases; Horses; Omeprazole; Stomach Ulcer; Ulcer | 2023 |
Changes in Heart Rate Variability with Induction of Gastric Ulcers in Adult Horses.
Topics: Animals; Anti-Ulcer Agents; Heart Rate; Horse Diseases; Horses; Omeprazole; Stomach Ulcer; Ulcer | 2023 |
Changes in Heart Rate Variability with Induction of Gastric Ulcers in Adult Horses.
Topics: Animals; Anti-Ulcer Agents; Heart Rate; Horse Diseases; Horses; Omeprazole; Stomach Ulcer; Ulcer | 2023 |
Changes in Heart Rate Variability with Induction of Gastric Ulcers in Adult Horses.
Topics: Animals; Anti-Ulcer Agents; Heart Rate; Horse Diseases; Horses; Omeprazole; Stomach Ulcer; Ulcer | 2023 |
A Comparison of the Efficacy of Two Omeprazole Formulations in the Treatment of Equine Gastric Ulcer Syndrome in Racehorses: A Blinded, Randomized Clinical Trial.
Topics: Animals; Anti-Ulcer Agents; Carcinoma, Squamous Cell; Horse Diseases; Horses; Omeprazole; Powders; S | 2023 |
Effect of Changing Diet on Gastric Ulceration in Exercising Horses and Ponies After Cessation of Omeprazole Treatment.
Topics: Animals; Gastroscopy; Horse Diseases; Horses; Omeprazole; Physical Conditioning, Animal; Stomach Ulc | 2019 |
Impact of concurrent treatment with omeprazole on phenylbutazone-induced equine gastric ulcer syndrome (EGUS).
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Horse Diseases; Horses; Omeprazole; Phenylbutazone | 2021 |
Pharmacokinetic and pharmacodynamic effects of 2 registered omeprazole preparations and varying dose rates in horses.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Cross-Over Studies; Female; Horse Diseases; Horses | 2021 |
Preliminary investigations into a novel, long-acting, injectable, intramuscular formulation of omeprazole in the horse.
Topics: Animals; Anti-Ulcer Agents; Delayed-Action Preparations; Dosage Forms; Female; Gastric Acidity Deter | 2017 |
Pharmacokinetic and pharmacodynamic effects of two omeprazole formulations on stomach pH and gastric ulcer scores.
Topics: Animals; Anti-Ulcer Agents; Dosage Forms; Gastric Acidity Determination; Horse Diseases; Horses; Hyd | 2017 |
Comparison of aloe vera and omeprazole in the treatment of equine gastric ulcer syndrome.
Topics: Aloe; Animals; Female; Gels; Horse Diseases; Horses; Male; Omeprazole; Phytotherapy; Stomach Ulcer | 2018 |
Misoprostol is superior to combined omeprazole-sucralfate for the treatment of equine gastric glandular disease.
Topics: Animals; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastric Mucosa; Horse Diseases; Horse | 2019 |
A comparison of two doses of omeprazole in the treatment of equine gastric ulcer syndrome: a blinded, randomised, clinical trial.
Topics: Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Female; Horse Diseases; Horses; Male; | 2014 |
A comparison of three doses of omeprazole in the treatment of equine gastric ulcer syndrome: A blinded, randomised, dose-response clinical trial.
Topics: Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Female; Horse Diseases; Horses; Male; | 2015 |
Administration of trimethoprim-sulphadimidine does not improve healing of glandular gastric ulceration in horses receiving omeprazole: a randomised, blinded, clinical study.
Topics: Animals; Anti-Ulcer Agents; Female; Horse Diseases; Horses; Male; Omeprazole; Single-Blind Method; S | 2014 |
Efficacy of omeprazole paste in the prevention of gastric ulcers in 2 years old Thoroughbreds.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Horse Diseases; Horses; Omeprazole; Stomach Ulcer | 2012 |
Comparison of paste and suspension formulations of omeprazole in the healing of gastric ulcers in racehorses in active training.
Topics: Animals; Anti-Ulcer Agents; Cross-Over Studies; Horse Diseases; Horses; Ointments; Omeprazole; Physi | 2002 |
Efficacy of omeprazole paste for prevention of gastric ulcers in horses in race training.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Female; Horse Di | 2005 |
Efficacy of omeprazole paste for prevention of recurrence of gastric ulcers in horses in race training.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Female; Horse Di | 2005 |
Effects of treatment with omeprazole or ranitidine on gastric squamous ulceration in racing Thoroughbreds.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Cross-Over Studies; Female; Horse Diseases; Horses | 2005 |
Effects of short-term light to heavy exercise on gastric ulcer development in horses and efficacy of omeprazole paste in preventing gastric ulceration.
Topics: Animals; Anti-Ulcer Agents; Female; Horse Diseases; Horses; Male; Omeprazole; Physical Conditioning, | 2007 |
Effects of omeprazole on healing of naturally-occurring gastric ulcers in thoroughbred racehorses.
Topics: Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Female; Gastric Mucosa; Gastroscopy; H | 1997 |
Safety of omeprazole paste in foals and mature horses.
Topics: Administration, Oral; Animals; Animals, Newborn; Enzyme Inhibitors; Female; Horse Diseases; Horses; | 1999 |
Acceptability of a paste formulation and efficacy of high dose omeprazole in healing gastric ulcers in horses maintained in race training.
Topics: Administration, Oral; Animals; Double-Blind Method; Enzyme Inhibitors; Female; Gastroscopy; Horse Di | 1999 |
Effects of omeprazole paste on healing of spontaneous gastric ulcers in horses and foals: a field trial.
Topics: Administration, Oral; Age Factors; Animals; Animals, Newborn; Breeding; Double-Blind Method; Enzyme | 1999 |
Efficacy of omeprazole paste in the treatment and prevention of gastric ulcers in horses.
Topics: Administration, Oral; Animals; Enzyme Inhibitors; Female; Florida; Gastroscopy; Horse Diseases; Hors | 1999 |
Clinical trial to determine the effect of omeprazole given once or twice daily on gastric ulceration.
Topics: Administration, Oral; Animals; Double-Blind Method; Drug Administration Schedule; Enzyme Inhibitors; | 1999 |
22 other studies available for omeprazole and Equine Diseases
Article | Year |
---|---|
Evaluation of the treatment of equine glandular gastric disease with either long-acting-injectable or oral omeprazole.
Topics: Animals; Gastroscopy; Horse Diseases; Horses; Omeprazole; Retrospective Studies; Stomach Diseases | 2022 |
Does lesion type or severity predict outcome of therapy for horses with equine glandular gastric disease? - A retrospective study.
Topics: Animals; Horse Diseases; Horses; Misoprostol; Omeprazole; Retrospective Studies; Stomach Ulcer; Sucr | 2023 |
Does lesion type or severity predict outcome of therapy for horses with equine glandular gastric disease? - A retrospective study.
Topics: Animals; Horse Diseases; Horses; Misoprostol; Omeprazole; Retrospective Studies; Stomach Ulcer; Sucr | 2023 |
Does lesion type or severity predict outcome of therapy for horses with equine glandular gastric disease? - A retrospective study.
Topics: Animals; Horse Diseases; Horses; Misoprostol; Omeprazole; Retrospective Studies; Stomach Ulcer; Sucr | 2023 |
Does lesion type or severity predict outcome of therapy for horses with equine glandular gastric disease? - A retrospective study.
Topics: Animals; Horse Diseases; Horses; Misoprostol; Omeprazole; Retrospective Studies; Stomach Ulcer; Sucr | 2023 |
Five- versus seven-day dosing intervals of extended-release injectable omeprazole in the treatment of equine squamous and glandular gastric disease.
Topics: Animals; Carcinoma, Squamous Cell; Horse Diseases; Horses; Omeprazole; Retrospective Studies; Stomac | 2024 |
A study investigating the treatment of equine squamous gastric disease with long-acting injectable or oral omeprazole.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Female; Gastroscopy; Horse Diseases; Horses; Injec | 2020 |
Omeprazole Reduces Calcium Digestibility in Thoroughbred Horses.
Topics: Animals; Calcium, Dietary; Diet; Horse Diseases; Horses; Omeprazole; Proton Pump Inhibitors; Stomach | 2020 |
Effect of oral administration of omeprazole on the microbiota of the gastric glandular mucosa and feces of healthy horses.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Feces; Gastric Mucosa; Horse Diseases; Horses; Mi | 2020 |
A pilot study comparing the effect of orally administered esomeprazole and omeprazole on gastric fluid pH in horses.
Topics: Animals; Anti-Ulcer Agents; Esomeprazole; Horse Diseases; Horses; Hydrogen-Ion Concentration; Omepra | 2017 |
Comparison of the effect of two doses of omeprazole on the squamous gastric mucosa in thoroughbred racehorses.
Topics: Animals; Anti-Ulcer Agents; Breeding; Dose-Response Relationship, Drug; Female; Gastric Mucosa; Hors | 2014 |
Occupational contact dermatitis caused by omeprazole in a veterinary medicament.
Topics: Animals; Dermatitis, Allergic Contact; Dermatitis, Occupational; Gastroesophageal Reflux; Horse Dise | 2014 |
Occupational allergic contact dermatitis caused by omeprazole in a horse breeder.
Topics: Adult; Animals; Cross Reactions; Dermatitis, Allergic Contact; Dermatitis, Occupational; Female; Hor | 2014 |
The effects of dose and diet on the pharmacodynamics of omeprazole in the horse.
Topics: Animals; Anti-Ulcer Agents; Cross-Over Studies; Diet; Dose-Response Relationship, Drug; Gastric Acid | 2017 |
Effect of gastric ulceration on physiologic responses to exercise in horses.
Topics: Animals; Anti-Ulcer Agents; Female; Food Deprivation; Gastric Mucosa; Horse Diseases; Horses; Male; | 2009 |
Ulcerative cystitis associated with phenylbutazone administration in two horses.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cystitis; Hematuria; Horse Dise | 2011 |
Treatment with histamine-type 2 receptor antagonists and omeprazole increase the risk of diarrhoea in neonatal foals treated in intensive care units.
Topics: Animals; Animals, Newborn; Anti-Ulcer Agents; Clostridium Infections; Diarrhea; Female; Histamine H2 | 2012 |
Efficacy of a paste formulation of omeprazole for the treatment of naturally occurring gastric ulcers in training standardbred racehorses in Canada.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Female; Gastrosc | 2003 |
Odds of moderate or severe gastric ulceration in racehorses receiving antiulcer medications.
Topics: Age Factors; Animals; Anti-Ulcer Agents; Breeding; Case-Control Studies; Female; Gastroscopy; Horse | 2003 |
Effect of GastroGard and three compounded oral omeprazole preparations on 24 h intragastric pH in gastrically cannulated mature horses.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Drug Compounding; Female; Gastric Acid; Gastric Mu | 2003 |
Evaluation of urine sucrose concentration for detection of gastric ulcers in horses.
Topics: Animals; Anti-Ulcer Agents; Chromatography, High Pressure Liquid; Endoscopy; Horse Diseases; Horses; | 2004 |
Chronic diarrhea and weight loss in three horses.
Topics: Animals; Anti-Ulcer Agents; Desulfovibrionaceae Infections; Diarrhea; Endoscopy, Gastrointestinal; E | 2006 |
Cholelithiasis and hepatic fibrosis in a standardbred mare.
Topics: Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Blood Cell Count; Blood Chemical Analysis | 2006 |
The effect of omeprazole paste on intragastric pH in clinically ill neonatal foals.
Topics: Administration, Oral; Animals; Animals, Newborn; Anti-Ulcer Agents; Female; Gastric Acid; Gastric Ac | 2008 |
Effects of orally administered enteric-coated omeprazole on gastric acid secretion in horses.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Female; Gastric Acidity Determination; Gastric Jui | 1999 |